Miner CM - Search Results

1

Safety and efficacy of fluoxetine in patients who receive oral contraceptive therapy.

Koke SC, Brown EB, Miner CM. Koke SC, et al. Among authors: miner cm. Am J Obstet Gynecol. 2002 Sep;187(3):551-5. doi: 10.1067/mob.2002.124939. Am J Obstet Gynecol. 2002. PMID: 12237626 Clinical Trial.

2

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

Miner C, Brown E, McCray S, Gonzales J, Wohlreich M. Miner C, et al. Clin Ther. 2002 Mar;24(3):417-33. doi: 10.1016/s0149-2918(02)85043-3. Clin Ther. 2002. PMID: 11952025 Clinical Trial.

3

Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.

Miner CM, Brown EB, Gonzales JS, Munir R. Miner CM, et al. J Clin Psychiatry. 2002 Mar;63(3):232-40. doi: 10.4088/jcp.v63n0310. J Clin Psychiatry. 2002. PMID: 11926723 Clinical Trial.

4

Recurrence of symptoms of premenstrual dysphoric disorder after the cessation of luteal-phase fluoxetine treatment.

Pearlstein T, Joliat MJ, Brown EB, Miner CM. Pearlstein T, et al. Among authors: miner cm. Am J Obstet Gynecol. 2003 Apr;188(4):887-95. doi: 10.1067/mob.2003.207. Am J Obstet Gynecol. 2003. PMID: 12712081

5

Safety of subchronic treatment with fluoxetine for major depressive disorder in children and adolescents.

Nilsson M, Joliat MJ, Miner CM, Brown EB, Heiligenstein JH. Nilsson M, et al. Among authors: miner cm. J Child Adolesc Psychopharmacol. 2004 Fall;14(3):412-7. doi: 10.1089/cap.2004.14.412. J Child Adolesc Psychopharmacol. 2004. PMID: 15650497 Clinical Trial.

6

Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.

Joliat MJ, Brown EB, Miner CM. Joliat MJ, et al. Among authors: miner cm. J Clin Psychopharmacol. 2004 Aug;24(4):464-7. doi: 10.1097/01.jcp.0000132345.35713.16. J Clin Psychopharmacol. 2004. PMID: 15232349 No abstract available.

7

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries.

Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, McCray S. Cohen LS, et al. Obstet Gynecol. 2002 Sep;100(3):435-44. doi: 10.1016/s0029-7844(02)02166-x. Obstet Gynecol. 2002. PMID: 12220761 Clinical Trial.

8

Long-term treatment outcomes of depression with associated anxiety: efficacy of continuation treatment with fluoxetine.

Joliat MJ, Schmidt ME, Fava M, Zhang S, Michelson D, Trapp NJ, Miner CM. Joliat MJ, et al. Among authors: miner cm. J Clin Psychiatry. 2004 Mar;65(3):373-8. doi: 10.4088/jcp.v65n0313. J Clin Psychiatry. 2004. PMID: 15096077 Clinical Trial.

9

Brain fluoxetine measurements using fluorine magnetic resonance spectroscopy in patients with social phobia.

Miner CM, Davidson JR, Potts NL, Tupler LA, Charles HC, Krishnan KR. Miner CM, et al. Biol Psychiatry. 1995 Nov 15;38(10):696-8. doi: 10.1016/0006-3223(95)00287-1. Biol Psychiatry. 1995. PMID: 8555383 No abstract available.

10

Discontinuation of clonazepam in the treatment of social phobia.

Connor KM, Davidson JR, Potts NL, Tupler LA, Miner CM, Malik ML, Book SW, Colket JT, Ferrell F. Connor KM, et al. Among authors: miner cm. J Clin Psychopharmacol. 1998 Oct;18(5):373-8. doi: 10.1097/00004714-199810000-00004. J Clin Psychopharmacol. 1998. PMID: 9790154 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page